Trial Profile
Rhode Island Diastolic Dysfunction - Heart Failure
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Sapropterin (Primary)
- Indications Heart failure; Hypertension
- Focus Therapeutic Use
- Acronyms RIDD-HF
- 28 Jan 2019 Status changed from recruiting to completed.
- 09 Apr 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
- 20 Oct 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.